readthroughSign in
CompanyCRVSNasdaqSouth San Francisco, CA

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals develops ITK inhibitors for immune diseases and cancer.

SCHEDULE 13GNov 10Latest SEC filing
Nov 5Latest story